As shown in Figure 3, BC patients with higher mRNA expression of ANXA1 (HR = 1.97, logrank P = 7.3e-06), ANXA2 (HR = 1.82, logrank P = 1.4e-04), ANXA3 (HR = 1.38, logrank P = 0.037), ANXA5 (HR = 1.75, logrank P = 1.7e-04), ANXA6 (HR = 1.65, logrank P = 1.6e-03), and ANXA7 (HR = 1.42, logrank P = 0.029) had shorter OS. Here, ANXA3 is linked to breast cancer.